2. UroToday Home
  3. Categories
  4. Conferences

AUA 2014

auaAmerican Urological Association (AUA)
Annual Meeting
May 16 - 21, 2014

Orlando, Florida USA

#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection

ORLANDO, FL USA (UroToday.com) - Presented by David Sussman,1 Jennifer Gruenenfelder,2 Heinrich Schulte-Baukloh,3 Steven Guard,4 Yan Zheng,5 and Karel Everaert6 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy

ORLANDO, FL USA (UroToday.com) - Presented by Jay T. Bishoff,1 Stephen J. Freedland,2 Leah Gerber,3 Pierre Tennstedt,4 Julia Reid,5 William Welbourn,5 Markus Graefen,4 Zaina Sangale,5 Eliso Tikishvili,5 Jimmy Park,5 Adib Younus,5 Alexander Gutin,5 Jerry S. Lanchbury,5 Guido Sauter,6 Michael Brawer,5 Steven Stone,5 and Thorsten Schlomm4 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Validation of a 46-gene cell cycle progression (CCP) RNA signature for predicting prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort

ORLANDO, FL USA (UroToday.com) - Presented by Jack Cuzick, Steven Stone, Zi Hua Yang, Julia Reid, Gabrielle Fisher, Daniel Berney, Luis Beltran, Henrik Moller, David Greenberg, Michael Brawer, Alexander Gutin, Jerry Lanchbury, and Peter Scardino at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7

ORLANDO, FL USA (UroToday.com) - Presented by Matthew Cooperberg, Stephen J. Freedland, Thorsten Schlomm, Julia E. Reid, Steven Stone, and Michael K. Brawer at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence

ORLANDO, FL USA (UroToday.com) - Presented by Michael B. Chancellor,1 Riya Pulicharam,2 I-Ning Cheng,2 Karen Campbell,3 Catherine Corbell,3 Manher Joshi,3 and Denise Globe3 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Impact of female stress urinary incontinence surgery on pre-op overactive bladder symptoms - Session Highlights

ORLANDO, FL USA (UroToday.com) - The aim of this study was to describe the impact of various stress urinary incontinence (SUI) procedures on pre-operative overactive bladder (OAB) symptoms, up to 5 years after surgery.

#AUA14 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED

ORLANDO, FL USA (UroToday.com) - Presented by Matthew R. Cooperberg,1 Oliver Sartor,2 Andrew J. Armstrong,3 Christopher M. Pieczonka,4 Raoul S. Concepcion,5 Vahan Kassabian,6 Ronald F. Tutrone,7 James L. Bailen,8 Neal D. Shore,9Lawrence I. Karsh,10 Bernard L. Hertzman,11 David F. Penson,12 Candice Mccoy,13 Andrew Sandler,13 Robert C. Tyler,13 James B. Whitmore,13 and Celestia S. Higano14 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial

ORLANDO, FL USA (UroToday.com) - Presented by Neal D. Shore,1 Nicholas J. Vogelzang,2 Peter Hoskin,3 Sten Nilsson,4 Robert Coleman,5 Christopher Parker,6 Mona Wahba,7 Karin Staudacher,8 and Oliver Sartor9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Impact of prior endocrine therapy on clinical benefit of abiraterone acetate in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302

ORLANDO, FL USA (UroToday.com) - Presented by Fred Saad,1 Thian Kheoh,2 Margaret K. Yu,2 Matthew R. Smith,3 Eric J. Small,4 Peter F.A. Mulders,5 Karim Fizazi,6 Dana E. Rathkopf,7 Stéphane Oudard,8 Howard I. Scher,7 Joaquim Bellmunt,9 Mary-Ellen Taplin,9 Ian D. Davis,10 Dirk Schrijvers,11 Andrew Protheroe,12 Arturo Molina,13 Thomas W. Griffin,2 Johann S. de Bono,14 and Charles J. Ryan4 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy

ORLANDO, FL USA (UroToday.com) - Presented by Melissa Thompson,1 Tracy Li,2 Mary B. Todd,2 Margaret K. Yu,4 Thian Kheoh,3 Jianming He,2 and Ryan Saadi2 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Page 2 of 18